NFKB1 and breast cancer: highlighted that SEVs released from breast cancer cells activated NF-κB pathway in breast epithelium cells under hypoxic conditions, then promoted the release of inflammatory cytokines and mitochondria-mediated cell migration, which enabled the disruption of the mammary glandular vesicle structure.